How to Choose Digital Rehabilitation Tools

Introduction

Families are surrounded by rehabilitation apps, online exercises, serious games, interactive screens, wearable sensors and virtual-reality products. Their marketing may promise engagement or measurable progress, but no single tool suits every person. The right choice begins with a meaningful activity, the person’s preferences and a qualified professional’s assessment. Cost, accessibility, safety, privacy and long-term usefulness matter more than technological novelty.

Start with everyday goals, not devices

A digital tool should help answer a real question: Can the child prepare for school more independently? Can an adult after stroke practise a meaningful upper-limb task? Can someone communicate a choice more easily? Can an older adult remain connected with their community? Identify the activity, current barriers, support already available and what an improvement would look like. A game score is not itself a participation outcome.

Understand the main technology categories

Visual schedules and accessible educational tools: can make routines and instructions clearer.
Communication supports and AAC: enable expression and participation when carefully selected with relevant professionals.
Interactive games and movement tracking: may structure practice and collect selected performance indicators, though not every metric is clinically validated.
Video consultations and telerehabilitation: facilitate selected types of follow-up and caregiver education.
VR, AR and mixed reality: may provide adjustable simulated environments but require suitability, age guidance and supervision.
AI-based tools: may support adaptation of educational materials and activity prototypes but require careful clinical review.

Seven criteria for evaluating a tool

Goal: Does it help achieve a meaningful functional objective?
Accessibility: Are language, vision, hearing, motor control, cognition and preferred input accommodated?
Individualization: Can difficulty, speed, feedback, sensory intensity and assistance be adjusted?
Evidence: Is research available for this population, task and outcome—not just the technology category?
Safety: Is the activity suitable for the person’s health, age and supervision requirements?
Privacy: What information is collected, transmitted, retained or shared?
Practicality: What is the full cost, device compatibility, maintenance burden and offline alternative?

The best tool may be a printable routine, a low-cost accessibility setting or an established assistive device. A more immersive solution is not automatically better.

Therapists need new AI skills—not to replace clinical expertise, but to extend it

Technology now changes faster than traditional clinical procurement cycles. Therapists increasingly need to update their digital literacy and learn how to use artificial intelligence responsibly—not only to choose existing software, but also to prototype and co-create tools tailored to the needs they encounter in practice.

With appropriate AI-assisted design and low-code or “vibe coding” workflows, a clinician may develop a simple visual schedule, an accessible memory game, a sequencing task, a printable activity, a multilingual educational aid or a web-based interactive prototype. This can shorten the distance between an observed need and a usable educational or therapeutic support.

For example, an occupational therapist could prototype a shopping-list sequencing activity with adjustable distractors; a speech-language therapist might outline a customizable vocabulary activity; or a physiotherapist could help specify a movement-feedback interface. In every case, the therapist defines the clinical objective, meaningful activity, adaptations and evaluation criteria. The AI helps with drafting or implementation; it does not independently establish efficacy or safety.

Being an augmented therapist means using AI to expand professional capability, not becoming dependent on it. New tools require testing for accessibility, usability, bias, cybersecurity, data protection and clinical risk before real-world deployment. Tools that influence medical decisions or make therapeutic claims may fall under applicable medical-device or professional regulations. Families should never be asked to use an unvalidated experimental prototype as a substitute for prescribed care.

A practical AI-assisted creation workflow

Observe: describe a functional barrier encountered during a meaningful activity.
Understand: assess the person, context, safety concerns and existing alternatives.
Imagine: define what an adaptable tool should do, without choosing technology prematurely.
Create with AI: draft text, visual materials or a prototype using fictional or de-identified examples.
Personalize: adjust task difficulty, interface, language, sensory demands and input methods.
Test: check functionality, accessibility and safety under appropriate professional oversight.
Adapt: review actual participation, feedback and unintended effects before wider use.

This workflow is a design method, not a clinical validation protocol. Sensitive patient data should not be entered into consumer AI services without an appropriate legal and organizational framework.

Personalization: the therapist and family as co-designers

A child may need larger buttons, fewer distractions and shorter instructions; an adult may need slower pacing or alternative input; an older person may prefer a printed checklist to a complicated app. Families understand everyday barriers and preferences. Therapists contribute assessment, risk management and knowledge of functional goals. Together they can define useful features and decide whether technology genuinely adds value.

Where possible, design tools so the person can choose, pause and express discomfort. Accessibility should be part of the initial brief, not an afterthought.

How Remotion approaches therapist-centred tools

Remotion develops interactive rehabilitation activities across different devices with an emphasis on professional control and adaptation. In Remotion Classic, therapists can use a library of exercises and games. Remotion TheraVerse explores customizable virtual environments, including a virtual room in which a therapist can place interactive objects and integrate visual, auditory and vibration-based haptic cues through compatible hardware.

These capabilities illustrate a broader design principle: practitioners should be able to adjust the environment and activities to functional objectives rather than forcing all patients through a fixed experience. They do not, by themselves, establish clinical effectiveness for a particular condition. Individual suitability and outcomes still require professional evaluation.

Questions families can ask before purchasing

What specific daily-life goal will this help?
Who selected the tool, and is a professional able to supervise or adjust its use?
What evidence supports the intended use?
Can the person control difficulty, sensory load and breaks?
What physical or medical risks should we consider?
How will we know whether skills transfer outside the app?
Does the tool collect identifiable health or child data?
What will we pay over time, and what happens if the service ends?
Is there a simpler or non-digital alternative?

Illustrative family scenarios

A child developing independence in school preparation

The occupational therapist and family agree that a visual sequence could reduce prompting. They first try a paper checklist; if useful, they may prototype a personalized digital version with pictures and language chosen with the child. Success is measured by meaningful independence, not app use.

An adult practising a meaningful activity after stroke

A clinician selects a suitable interactive task that complements real-life practice and sets clear safety limits. The family helps with setup rather than changing therapeutic difficulty independently. Progress is reviewed in actual daily occupations.

A therapist addressing an unmet accessibility need

A professional uses AI-assisted prototyping to create a simplified interactive activity with larger targets and fewer visual distractors. The prototype is tested for functionality and accessibility before any supervised clinical use; it is not presented as an established treatment merely because it works technically.

Safety, regulation and digital equity

Children, older adults and people with cognitive, sensory or motor differences may need additional accessibility and supervision. Check age and device policies for immersive headsets. Stop activities that cause dizziness, pain, distress, loss of balance or other concerning symptoms, and obtain clinical advice where appropriate. Do not treat AI recommendations as diagnoses or prescriptions.

Clinical software can create risks involving personal data, account security, accessibility and inaccurate feedback. Developers and organizations must assess applicable privacy and medical-device requirements. A household without broadband, subscriptions or a modern computer should still be offered appropriate care and accessible alternatives.

Regulatory reminder: Europe, the United States and the Middle East

AI-assisted prototyping can help therapists create tools more quickly, but technical feasibility does not establish legal authorization, clinical validity or medical-device compliance. Requirements depend on the tool’s intended purpose, claims, functions, users, data practices and market. A visual timetable for general education is not necessarily regulated like software intended to diagnose a condition, recommend treatment or guide clinical decisions.

European Union

Health and other personal data must be handled in accordance with the General Data Protection Regulation (GDPR), including an appropriate legal basis, safeguards and consideration of sensitive data. Software with a medical intended purpose may qualify as a medical device under Regulation (EU) 2017/745 (MDR); classification and conformity assessment depend on its actual functions and intended use. The European Commission’s MDCG 2019-11 rev.1 software guidance helps explain qualification and classification. The EU AI Act adds certain requirements for AI and AI literacy, with phased application dates and ongoing legislative developments; check the latest official timetable rather than assuming all high-risk obligations apply from the same date.

United States

The US Food and Drug Administration (FDA) regulates software functions that meet the medical-device definition, based on intended use and risk; some low-risk wellness or qualifying clinical decision-support functions may fall outside specific device oversight. See the FDA’s January 2026 clinical decision-support guidance and its device software policy. HIPAA applies to covered entities and business associates in the defined circumstances—not automatically to every consumer health app. Other apps can be subject to Federal Trade Commission requirements, including the Health Breach Notification Rule.

Middle East: country-specific rules

There is no single medical-software or health-data regulation covering the entire Middle East. In Saudi Arabia, the Saudi Food and Drug Authority (SFDA) publishes Guidance on Digital Health Products (MDS-G027), including software as a medical device, AI/ML, VR/AR and digital therapeutics; medical-device marketing authorization may apply according to the product and claims. In the United Arab Emirates, medical-device marketing authorization pathways and the Federal Law No. 2 of 2019 on ICT in Health Fields are relevant, alongside local health-authority requirements. In Qatar, Law No. 13 of 2016 on Personal Data Privacy Protection is a key data-protection reference; applicable healthcare and medical-product requirements should be checked with the competent authorities before deployment.

Practical rule for therapists and developers: document the intended purpose, distinguish education and wellness from medical claims, check clinical safety and evidence, minimize patient data, protect children’s information, assess cybersecurity and obtain regulatory or legal advice before distributing a patient-facing clinical application. These are general pointers, not a formal classification or legal opinion.

Frequently asked questions

Does a more expensive rehabilitation device produce better outcomes?

Not necessarily. Appropriateness and evidence for the specific goal matter more than price or immersion.

Can parents use AI to create an activity for their child?

Families may draft non-clinical educational materials, but individualized rehabilitation activities and safety-sensitive adaptations should be reviewed by the relevant professional.

Should all therapists learn to code?

No. They should develop sufficient AI and digital literacy to evaluate tools, specify needs, collaborate with developers and critically assess prototypes. Some may choose to build simple tools using low-code workflows.

Can a prototype be used as medical treatment immediately?

No. Technical functionality is not clinical validation. Appropriate testing, risk controls and regulatory assessment may be required.

How do we know a digital tool works for our family?

Agree on measurable everyday goals, monitor comfort and burden, and review functional outcomes with the care team.

Conclusion

The future of rehabilitation is not a contest between clinicians and technology. Families benefit when professionals combine clinical reasoning with digital literacy, adaptable tools and a willingness to co-create. Artificial intelligence can help therapists produce better-fitting resources more rapidly, but the human remains responsible for deciding what is meaningful, appropriate and safe. Choose technology that serves participation—never participation that serves the technology.

References and further reading

World Health Organization. Rehabilitation.
World Health Organization. Ethics and governance of artificial intelligence for health: Guidance on large multi-modal models (2024).
World Health Organization. Assistive technology.
UNICEF. Policy guidance on AI for children.